The robust 77.8% three-month CR rate observed in the UTOPIA trial is highly encouraging and reinforces the potential of UGN-103 to deliver meaningful benefits to patients,” said Liz Barrett, President ...
The oxygen evolution reaction is more relevant to your daily life than you would think. It is used in many electrochemical ...